Farmington Family Medicine Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 N 1075 W, Suite # 220, Farmington, UT 84025 Phone: 801-451-4538 Fax: 801-451-2295 |
Tanner Memorial Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 444 W Bourne Cir, Farmington, UT 84025 Phone: 801-773-4840 Fax: 801-525-8151 |
Lakeview Internal Medicine And Surgery Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 444 W Bourne Cir Ste 101, Farmington, UT 84025 Phone: 801-294-9333 Fax: 801-294-7558 |
Orn Total Health Family Medicine Medicare: Medicare Enrolled Practice Location: 722 Shepard Ln, Ste 102, Farmington, UT 84025 Phone: 801-388-5129 |
Tuta Sano Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 57 W Grove Creek Cir, Farmington, UT 84025 Phone: 801-644-8968 |
Myndfull Care Management Utah Pc Internal Medicine Medicare: Medicare Enrolled Practice Location: 240 N East Promontory Ste C-200, Farmington, UT 84025 Phone: 855-839-8878 |
Mana Hrt, Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 736 W State St Apt G202, Farmington, UT 84025 Phone: 801-410-3804 |
Myndfull Care Utah Pc Internal Medicine Medicare: Medicare Enrolled Practice Location: 240 N East Promontory Ste C-200, Farmington, UT 84025 Phone: 855-839-8878 |
News Archive
The rate of Sudden Infant Death Syndrome (SIDS), a leading cause of infant mortality, declined in New Jersey by 45 percent between 2000 and 2006, the most recent year for which final SIDS data are available, report Barbara M. Ostfeld, PhD, and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School and program director and medical director, respectively, for the Sudden Infant Death Syndrome (SIDS) Center of New Jersey.
Children and teens with obsessive-compulsive disorder (OCD) who were receiving some benefit from treatment with medication had a significantly greater reduction in OCD symptoms with the addition of cognitive behavior therapy, according to a study in the September 21 issue of JAMA.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
Almost one-third of families whose children were being treated for cancer faced food, housing or energy insecurity and one-quarter lost more than 40 percent of household income, according to a new study from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Radiation from Japan's Fukushima Daiichi nuclear disaster may eventually cause anywhere from 15 to 1,300 deaths and from 24 to 2,500 cases of cancer, mostly in Japan, Stanford researchers have calculated.
› Verified 5 days ago